BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37000620)

  • 21. Protocol to package and concentrate adeno-associated virus serotype 8 for use in autochthonous mouse models of pancreatic cancer.
    Zhuo M; Mao J; David CJ
    STAR Protoc; 2023 Mar; 4(1):102108. PubMed ID: 36853729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protocol for IPO11 deletion and re-expression in H460 lung cancer cells using CRISPR-Cas9 and plasmid transfection.
    Zhang Y; Ou G; Zhou Z; Wang J; Yang H
    STAR Protoc; 2023 May; 4(2):102317. PubMed ID: 37195868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR-based large-scale modeling of loss-of-function mutations to investigate mechanisms of stress resistance in cancer.
    Simeoni F; Loukas I; Wilson TS; Scaffidi P
    STAR Protoc; 2023 Mar; 4(1):102097. PubMed ID: 36853711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR-Cas9-induced gene knockout in zebrafish.
    Medishetti R; Balamurugan K; Yadavalli K; Rani R; Sevilimedu A; Challa AK; Parsa K; Chatti K
    STAR Protoc; 2022 Dec; 3(4):101779. PubMed ID: 36317180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Drug Resistance Genes Using a Pooled Lentiviral CRISPR/Cas9 Screening Approach.
    Kerek EM; Cromwell CR; Hubbard BP
    Methods Mol Biol; 2021; 2381():227-242. PubMed ID: 34590280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation and single-cell RNA-seq analyses of human pluripotent-stem-cell-derived renal organoids.
    Lian E; Pietrobon A; Stanford WL
    STAR Protoc; 2023 May; 4(2):102314. PubMed ID: 37220001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR/Cas-based customization of pooled CRISPR libraries.
    Kweon J; Kim DE; Jang AH; Kim Y
    PLoS One; 2018; 13(6):e0199473. PubMed ID: 29924860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of endogenously tagged E-cadherin cells using gene editing via non-homologous end joining.
    Rimmer N; Liang CY; Coelho R; Lopez MN; Jacob F
    STAR Protoc; 2023 May; 4(2):102305. PubMed ID: 37178110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protocol for gene characterization in Aspergillus niger using 5S rRNA-CRISPR-Cas9-mediated Tet-on inducible promoter exchange.
    Zheng X; Cairns T; Zheng P; Meyer V; Sun J
    STAR Protoc; 2022 Dec; 3(4):101838. PubMed ID: 36595926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of CRISPR/Cas9 Pooled Screening for a Non-immediate Readout Model.
    Terzi Çizmecioglu N
    Methods Mol Biol; 2024 Mar; ():. PubMed ID: 38441725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adding a Chemical Biology Twist to CRISPR Screening.
    Huang S; Baskin JM
    Isr J Chem; 2023 Feb; 63(1-2):. PubMed ID: 37588264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR Library Screening in Cultured Cardiomyocytes.
    DeLuca S; Bursac N
    Methods Mol Biol; 2022; 2485():1-13. PubMed ID: 35618895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR-Cas9 screen in human embryonic stem cells to identify genes required for neural differentiation.
    Qi S; Sivakumar S; Yu H
    STAR Protoc; 2022 Dec; 3(4):101682. PubMed ID: 36115024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protocol to study sufficiency of
    Pachano T; Rada-Iglesias A
    STAR Protoc; 2022 Sep; 3(3):101492. PubMed ID: 35769926
    [No Abstract]   [Full Text] [Related]  

  • 35. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening.
    Joung J; Konermann S; Gootenberg JS; Abudayyeh OO; Platt RJ; Brigham MD; Sanjana NE; Zhang F
    Nat Protoc; 2017 Apr; 12(4):828-863. PubMed ID: 28333914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines.
    Gao P; Dong X; Wang Y; Wei GH
    STAR Protoc; 2021 Jun; 2(2):100419. PubMed ID: 33870225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Creating a RAW264.7 CRISPR-Cas9 Genome Wide Library.
    Napier BA; Monack DM
    Bio Protoc; 2017 May; 7(10):. PubMed ID: 28868328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploiting CRISPR/Cas9 to engineer precise segmental deletions in mouse embryonic stem cells.
    Elango R; Panday A; Willis NA; Scully R
    STAR Protoc; 2022 Sep; 3(3):101551. PubMed ID: 36042887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome editing in
    Sinha T; Yazdani SS
    STAR Protoc; 2022 Sep; 3(3):101629. PubMed ID: 36042883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimized protocols for efficient gene editing in mouse hepatocytes
    Chen Y; Ding Q
    STAR Protoc; 2022 Mar; 3(1):101062. PubMed ID: 35005644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.